Butyrate, generated by gut microbiota, and its therapeutic role in metabolic syndrome.

@article{Bridgeman2020ButyrateGB,
  title={Butyrate, generated by gut microbiota, and its therapeutic role in metabolic syndrome.},
  author={Stephanie Bridgeman and Wendy Northrop and Phillip E. Melton and Gaewyn Ellison and Philip Newsholme and Cyril Desire Sylvain Mamotte},
  journal={Pharmacological research},
  year={2020},
  pages={
          105174
        }
}
Metabolic syndrome (MetS) and the associated incidence of cardiovascular disease and type 2 diabetes represents a significant contributor to morbidity and mortality worldwide. Butyrate, a short-chain fatty acid produced by the gut microbiome, has long been known to promote growth in farmed animals and more recently has been reported to improve body weight and composition, lipid profile, insulin sensitivity and glycaemia in animal models of MetS. In vitro studies have examined the influence of… 
Effect of Advanced Glycation End-Products and Excessive Calorie Intake on Diet-Induced Chronic Low-Grade Inflammation Biomarkers in Murine Models
TLDR
This review provides a summary of research into biomarkers of diet-induced CLGI in murine models, with a focus on AGEs and obesogenic diets, and presents the physiological effects described in the literature.
Prospects for clinical applications of butyrate-producing bacteria
TLDR
Modulating gut microbiota with dietary approaches may improve intestinal dysbiosis commonly seen in patients with obesity-associated metabolic disorders and to help control obesity and metabolic syndrome.
Resveratrol Butyrate Esters Inhibit Obesity Caused by Perinatal Exposure to Bisphenol A in Female Offspring Rats
TLDR
RBE can suppress BPA-induced obesity in female offspring rats, and it demonstrates excellent modulatory activity on intestinal microbiota, with potential applications in perinatological research.
A Meta-Analysis of Microbial Therapy Against Metabolic Syndrome: Evidence From Randomized Controlled Trials
TLDR
In patients with MetS, the conditioning with microbial therapy notably improves FBG, TC, TG, HDL-C, LDL, WC, BMI, HOMA-IR, and DBP (except for the Study using Bifidobacteriumlactis), however, with no effect in SBP and in HbA1c%.
Connecting the dots: Targeting the microbiome in drug toxicity
TLDR
How the gut microbiota modulates drug toxicity by highlighting the microbiome, microbial enzymes or metabolites, drug metabolites, and host toxicological responses is focused on to facilitate the discovery of microbial targets and mechanisms associated with drug toxicity.
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase I
TLDR
Although protective effects ofHDAC inhibition have been observed in vivo, potent HDAC inhibition impairs β cell function in vitro, and the chronic low dose and acute high dose butyrate treatments may be more reflective of in vivo effects.
Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
TLDR
An 8 weeks treatment with B. breve BR03 and B632 had beneficial effects on insulin sensitivity in youths with obesity, and Tailored probiotic treatments could be an additional strategy for obesity.
Dietary nanoparticles alter the composition and function of the gut microbiota in mice at dose levels relevant for human exposure.
  • Laeticia Perez, E. Scarcello, +10 authors D. Lison
  • Medicine
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • 2021
TLDR
It is found that long-term oral exposure to dietary NPs at doses relevant for estimated human intakes disrupts the GM composition and function and does not appear associated with atheromatous or deleterious metabolic outcomes.
The melatonergic pathway and its interactions in modulating respiratory system disorders.
TLDR
The integration of melatonin's effects with the alpha 7 nicotinic receptor and the aryl hydrocarbon receptor in the regulation of mitochondrial function are proposed as a wider framework for understanding the role ofmelatonin across a wide array of diverse pulmonary disorders.
Lactobacillus plantarum HAC01 Supplementation Improves Glycemic Control in Prediabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
TLDR
This is the first clinical trial to show a beneficial effect of single-strain probiotic supplementation administered over eight weeks on HbA1c levels in prediabetic subjects.
...
1
2
...

References

SHOWING 1-10 OF 119 REFERENCES
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
TLDR
The role for gut microbiota-generated SCFA in protecting against the effects of energy dense diets offers an intriguing new avenue for regulating metabolic health and CVD risk.
Gut microbiome and metabolic syndrome.
TLDR
Modification of gut microbiota via prebiotics, probiotics or other dietary interventions has provided evidence to support a possible beneficial effect of interventions targeting gut microbiota modulation to treat components or complications of metabolic syndrome.
Gut microbiota and metabolic syndrome.
TLDR
Manipulation of gut microbiota through the administration of prebiotics or probiotics could reduce intestinal low grade inflammation and improve gut barrier integrity, thus, ameliorating metabolic balance and promoting weight loss.
Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
TLDR
Oral butyrate treatment beneficially affects glucose metabolism in lean but not metabolic syndrome subjects, presumably due to an altered SCFA handling in insulin‐resistant subjects.
Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice
TLDR
Hepatic mitochondria were identified as the main target of the beneficial effect of both butyrate-based compounds in reverting insulin resistance and fat accumulation in diet-induced obese mice, and the shift of the mitochondrial dynamic toward fusion bybutyrate and FBA resulted in the improvement of mitochondrial cell energy metabolism but also of glucose homeostasis.
Implications of butyrate and its derivatives for gut health and animal production
TLDR
Recent findings in animal research on butyrate and its derivatives in regard to their effects and mechanisms behind are critically reviewed and the implications of these findings for improving animal gut health and production are discussed.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
TLDR
Evidence that butyrate, a short-chain fatty acid produced by bacterial fermentation of fiber in the colon, can improve brain health is reviewed to hypothesize that the metabolism of a high fiber diet in the gut can alter gene expression in the brain to prevent neurodegeneration and promote regeneration.
Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases?
  • L. K. Brahe, A. Astrup, L. Larsen
  • Biology, Medicine
    Obesity reviews : an official journal of the International Association for the Study of Obesity
  • 2013
TLDR
It is suggested that butyrate might have an anti‐inflammatory potential that can alleviate obesity‐related metabolic complications, possibly due to its ability to enhance the intestinal barrier function.
Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity.
TLDR
Butyrate shows an obvious function of anti-obesity, and can alleviate the metabolic stress, maintain the β-cell function and protect them from inflammatory response in pregnant obese mouse without obvious fetus toxicity.
Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice
TLDR
Results showed that diet supplementation with butyrate inhibits the deleterious effects of high-fat diet intake on metabolic parameters and structure/function of several tissues/organs associated with type 2 diabetes mellitus in a mouse model, suggesting a potential use of this short-chain fatty acid in the treatment of this endocrine-metabolic disorder.
...
1
2
3
4
5
...